title: The role of small intestinal bacterial overgrowth in rosacea: A 3-year follow-up.
authors.affiliation: DISSAL Section of Dermatology, IRCCS University of Genoa-San Martino-IST Hospital, Italy.
authors.forename: Francesco
authors.initials: F
authors.lastname: Drago
authors.affiliation: DISSAL Section of Dermatology, IRCCS University of Genoa-San Martino-IST Hospital, Italy.
authors.forename: Elena
authors.initials: E
authors.lastname: De Col
authors.affiliation: DISSAL Section of Dermatology, IRCCS University of Genoa-San Martino-IST Hospital, Italy. Electronic address: a.agnoletti@virgilio.it.
authors.forename: Arianna Fay
authors.initials: AF
authors.lastname: Agnoletti
authors.affiliation: DISSAL Biostatistics Unit, IRCCS University of Genoa-San Martino-IST Hospital, Italy.
authors.forename: Irene
authors.initials: I
authors.lastname: Schiavetti
authors.affiliation: Department of Internal Medicine and Medical Specialities, IRCCS University of Genoa-San Martino-IST Hospital, Italy.
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Savarino
authors.affiliation: DISSAL Section of Dermatology, IRCCS University of Genoa-San Martino-IST Hospital, Italy.
authors.forename: Alfredo
authors.initials: A
authors.lastname: Rebora
authors.affiliation: DISSAL Section of Dermatology, IRCCS University of Genoa-San Martino-IST Hospital, Italy.
authors.forename: Stefania
authors.initials: S
authors.lastname: Paolino
authors.affiliation: DISSAL Section of Dermatology, IRCCS University of Genoa-San Martino-IST Hospital, Italy.
authors.forename: Emenuele
authors.initials: E
authors.lastname: Cozzani
authors.affiliation: DISSAL Section of Dermatology, IRCCS University of Genoa-San Martino-IST Hospital, Italy.
authors.forename: Aurora
authors.initials: A
authors.lastname: Parodi
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001765:Blind Loop Syndrome / Q000150:complications* / Q000188:drug therapy; D005500:Follow-Up Studies; D006801:Humans; D007421:Intestine, Small / Q000382:microbiology*; D008875:Middle Aged; D012074:Remission Induction; D012294:Rifamycins / Q000627:therapeutic use; D000078262:Rifaximin; D012393:Rosacea / Q000150:complications* / Q000382:microbiology* / Q000628:therapy
chemical_list: D000900:Anti-Bacterial Agents; D012294:Rifamycins; D000078262:Rifaximin